NEEDHAM, Mass.--(BUSINESS WIRE)--PTC (NASDAQ: PTC) today launched a new ThingWorx Studio augmented reality (AR) free trial program for the Industrial Internet of Things (IoT). The program enables ...
SOUTH PLAINFIELD, N.J., April 14, 2021 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) today introduced a new no-charge, patient-initiated testing program in the United States for individuals who ...
SOUTH PLAINFIELD, N.J., Sept. 7, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (PTCT) today announced the two recipients of its 2023 STRIVE Awards for Duchenne Muscular Dystrophy. Through the STRIVE ...
SOUTH PLAINFIELD, N.J., Jan. 17, 2023 /PRNewswire/ -- PTC Therapeutics (PTCT), Inc. (NASDAQ: PTCT) today announced the launch of the ninth annual STRIVE™ awards program. Through this program, PTC ...
BOSTON--(BUSINESS WIRE)--PTC (NASDAQ: PTC) has been recognized as a SiriusDecisions Program of the Year winner for the company's Revenue Orchestration and Intelligence Engine (ROI Engine) initiative, ...
SOUTH PLAINFIELD, N.J., June 10, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. PTCT today announced the launch of the Talent Pipeline Program (TPP), a one-year global internship program aimed at ...
SOUTH PLAINFIELD, N.J., Nov. 18, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the launch of a no-cost testing program for aromatic L-amino acid decarboxylase (AADC) ...
Free access to Creo+, Onshape, Codebeamer+, and a startup package for Arena to enable startups to meet the speed, complexity, and compliance demands of modern aerospace and defense product development ...
SOUTH PLAINFIELD, N.J., April 14, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today introduced a new no-charge, patient-initiated testing program in the United States for individuals ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback